The centrepiece of Framework Programme 9 is to be ten moonshot projects that inspire the public and connect people to EU R&D. Researchers are starting to pitch in with their ideas
Clinical trials are fundamental to the development of new treatments for cancer, but annual accrual to studies worldwide is low, at an estimated at three to five percent.
Paying hospitals for activity provides no incentive to improve. Using historical data, patients awaiting cardiac surgery can be profiled, with hospitals paid extra to bear the risk of complications, but receiving no further payment if a second operation is required
A government position paper avoids mention of money and the hard line stance on immigration is unchanged, but the UK aims to stay part of EU R&D - in a closer partnership than any of the 16 associated countries
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and the fortnightly R&D Express, tracking reforms and investments in central and eastern Europe.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.